Baxter - 38 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of April 25, 2019 is 76.25.
- The all-time high Baxter stock price is 81.77, which is 7.2% above the current share price.
- The Baxter 52-week high stock price is 81.77, which is 7.2% above the current share price.
- The Baxter 52-week low stock price is 61.39, which is 19.5% below the current share price.
- The average Baxter stock price for the last 52 weeks is 71.88.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 74.1129 | 65.3000 | 81.7700 | 64.4800 | 76.2500 | 15.85% |
| 2018 | 69.4960 | 66.4734 | 77.5850 | 61.3898 | 65.8200 | 2.89% |
| 2017 | 57.1307 | 43.5299 | 65.2059 | 43.5299 | 63.9697 | 47.29% |
| 2016 | 42.7447 | 35.9892 | 48.0126 | 33.6558 | 43.4320 | 17.58% |
| 2015 | 35.8127 | 37.5612 | 40.5418 | 31.1490 | 36.9381 | -1.63% |
| 2014 | 36.4733 | 34.4605 | 38.9020 | 33.1456 | 37.5510 | 8.40% |
| 2013 | 34.0089 | 32.7690 | 36.5433 | 31.5890 | 34.6398 | 7.28% |
| 2012 | 27.6880 | 23.8261 | 33.0998 | 23.4037 | 32.2894 | 38.42% |
| 2011 | 25.2865 | 23.2815 | 29.0669 | 22.2821 | 23.3264 | 0.05% |
| 2010 | 22.6492 | 26.1857 | 27.7221 | 18.3599 | 23.3138 | -11.56% |
| 2009 | 23.9992 | 24.2421 | 26.7293 | 20.6432 | 26.3609 | 11.76% |
| 2008 | 26.8008 | 25.0439 | 31.0609 | 21.2403 | 23.5863 | -6.24% |
| 2007 | 23.5704 | 19.8888 | 26.4740 | 19.8161 | 25.1566 | 26.79% |
| 2006 | 17.3015 | 16.1971 | 20.0000 | 14.9684 | 19.8418 | 24.81% |
| 2005 | 15.5204 | 14.4027 | 17.0361 | 13.8826 | 15.8974 | 10.63% |
| 2004 | 12.8813 | 12.3280 | 14.3902 | 11.7518 | 14.3694 | 15.22% |
| 2003 | 10.6657 | 11.4972 | 12.7080 | 7.4377 | 12.4710 | 11.14% |
| 2002 | 16.9595 | 20.8575 | 23.4107 | 9.5135 | 11.2207 | -46.73% |
| 2001 | 18.8187 | 17.4037 | 21.5532 | 15.8251 | 21.0657 | 22.85% |
| 2000 | 13.7315 | 11.7574 | 17.2096 | 9.9243 | 17.1474 | 42.52% |
| 1999 | 12.4071 | 11.8922 | 14.3487 | 11.1375 | 12.0314 | -0.50% |
| 1998 | 10.6685 | 9.2480 | 12.3640 | 8.9824 | 12.0917 | 29.95% |
| 1997 | 9.1662 | 7.3317 | 10.8583 | 7.3317 | 9.3052 | 25.77% |
| 1996 | 7.3765 | 6.7898 | 8.3344 | 6.5255 | 7.3984 | 8.29% |
| 1995 | 5.7141 | 4.4492 | 6.9334 | 4.2910 | 6.8322 | 51.57% |
| 1994 | 3.9589 | 3.7047 | 4.5077 | 3.3802 | 4.5077 | 21.68% |
| 1993 | 4.0087 | 4.6695 | 4.6695 | 3.0446 | 3.7047 | -21.89% |
| 1992 | 5.2015 | 5.6117 | 5.7376 | 4.4754 | 4.7427 | -17.07% |
| 1991 | 4.7862 | 3.8478 | 5.7733 | 3.6018 | 5.7190 | 45.97% |
| 1990 | 3.4144 | 3.4931 | 4.0527 | 2.8441 | 3.9180 | 14.41% |
| 1989 | 2.9065 | 2.3526 | 3.4899 | 2.3526 | 3.4246 | 45.57% |
| 1988 | 2.7255 | 3.0476 | 3.3902 | 2.1877 | 2.3526 | -20.70% |
| 1987 | 3.1453 | 2.4659 | 3.7793 | 2.3841 | 2.9668 | 18.75% |
| 1986 | 2.3554 | 2.0116 | 2.7410 | 1.9792 | 2.4983 | 22.22% |
| 1985 | 1.8960 | 1.7041 | 2.1570 | 1.6223 | 2.0441 | 19.95% |
| 1984 | 2.1153 | 3.0175 | 3.1797 | 1.5574 | 1.7041 | -43.53% |
| 1983 | 3.4721 | 3.0090 | 4.0642 | 2.7735 | 3.0175 | -3.89% |
| 1982 | 2.5174 | 2.2225 | 3.2770 | 2.0279 | 3.1395 | 44.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $38.988B | $11.127B |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $134.809B | 26.28 |
| Medtronic (MDT) | Ireland | $114.856B | 16.79 |
| Stryker (SYK) | United States | $69.039B | 24.64 |
| Boston Scientific (BSX) | United States | $49.279B | 23.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.460B | 16.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.746B | 0.00 |
| Canopy Growth (CGC) | Canada | $16.646B | 0.00 |
| ResMed (RMD) | United States | $14.578B | 27.64 |
| Aurora Cannabis (ACB) | Canada | $9.230B | 65.07 |
| Bio-Rad Laboratories (BIO) | United States | $8.754B | 50.22 |
| Perrigo (PRGO) | Ireland | $6.685B | 10.84 |
| Hill-Rom Holdings (HRC) | United States | $6.417B | 19.85 |
| Insulet (PODD) | United States | $4.971B | 1666.40 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.857B | 0.00 |
| ICU Medical (ICUI) | United States | $4.694B | 29.07 |
| Haemonetics (HAE) | United States | $4.319B | 38.31 |
| Hutchison China MediTech (HCM) | China | $3.951B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.335B | 0.00 |
| NuVasive (NUVA) | United States | $3.048B | 26.48 |
| Neogen (NEOG) | United States | $3.014B | 49.01 |
| Quidel (QDEL) | United States | $2.477B | 22.16 |
| National Vision Holdings (EYE) | United States | $2.284B | 44.94 |
| Aphria (APHA) | $1.955B | 0.00 | |
| HEXO (HEXO) | $1.502B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.342B | 19.28 |
| VAREX IMAGING (VREX) | United States | $1.234B | 24.16 |
| Cardiovascular Systems (CSII) | United States | $1.222B | 877.50 |
| AtriCure (ATRC) | United States | $1.081B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.962B | 26.00 |
| Omeros (OMER) | United States | $0.930B | 0.00 |
| PetIQ (PETQ) | United States | $0.874B | 25.02 |
| Cerus (CERS) | United States | $0.826B | 0.00 |
| MacroGenics (MGNX) | United States | $0.805B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.759B | 0.00 |
| Evolus (EOLS) | United States | $0.721B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.720B | 24.51 |
| TG Therapeutics (TGTX) | United States | $0.706B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.596B | 25.95 |
| Surmodics (SRDX) | United States | $0.585B | 85.02 |
| LeMaitre Vascular (LMAT) | United States | $0.554B | 26.32 |
| Meridian Bioscience (VIVO) | United States | $0.551B | 16.42 |
| Quanterix (QTRX) | United States | $0.500B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.344B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.321B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.319B | 20.75 |
| BioLife Solutions (BLFS) | United States | $0.308B | 127.08 |
| Vapotherm (VAPO) | United States | $0.283B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.263B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.223B | 0.00 |
| Owens & Minor (OMI) | United States | $0.214B | 2.93 |
| Zynex (ZYXI) | United States | $0.175B | 18.69 |
| Bovie Medical (APYX) | United States | $0.149B | 0.00 |
| Chimerix (CMRX) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 6.85 |
| Chembio Diagnostics (CEMI) | United States | $0.123B | 0.00 |
| Surface Oncology (SURF) | United States | $0.112B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 20.27 |
| Female Health (VERU) | United States | $0.086B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.083B | 0.00 |
| Neurotrope (NTRP) | United States | $0.076B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.067B | 19.86 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.066B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.049B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Senestech (SNES) | United States | $0.035B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.030B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.025B | 0.00 |
| Myomo (MYO) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.017B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 12.64 |
